O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-9.96%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.16B
AUM Growth
+$6.16B
(-21%)
Cap. Flow
-$479M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
32.31%
Holding
169
New
10
Increased
33
Reduced
25
Closed
28
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$85.3M |
| 2 |
Pfizer
PFE
|
$66.8M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$60.6M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$54.6M |
| 5 |
argenx
ARGX
|
$53.5M |
Top Sells
| 1 |
Merck
MRK
|
$136M |
| 2 |
Bristol-Myers Squibb
BMY
|
$126M |
| 3 |
HCA Healthcare
HCA
|
$100M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$80.7M |
| 5 |
SVA
Sinovac Biotech, Ltd
SVA
|
$72.7M |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Industrials | 0% |
